Sign in

CIK 0001716166

  • Non-accelerated filer
  • Smaller reporting company

Vivos Therapeutics, Inc.

Sign in to watch
Ticker
VVOS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813224056
Phone
+1 866-908-4867
Business address
7921 SOUTHPARK PLAZA,, SUITE 210, LITTLETON, CO, 80120
Former names
Vivos BioTechnologies, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-30 Huntsman Ronald Kirk Chief Executive Officer Other acquisition +85,910 $0.58 $50K 85,910
2026-06-30 Huntsman Ronald Kirk Chief Executive Officer Other acquisition · Warrant (Right to Buy) +85,910 $0.58 $50K 85,910
2024-11-26 Huntsman Ronald Kirk Chief Executive Officer Grant or award · Stock Option (Right to Buy) +315,421 $2.64 $833K 364,755
2024-06-20 Huntsman Ronald Kirk Chief Executive Officer Grant or award · Stock Option (Right to Buy) +20,000 $2.38 $48K 49,334
2023-06-20 Huntsman Ronald Kirk Chief Executive Officer Purchase +14,000 $0.53 $7K 86,521
2023-06-16 Huntsman Ronald Kirk Chief Executive Officer Purchase +10,000 $0.54 $5K 67,521
2023-06-16 Huntsman Ronald Kirk Chief Executive Officer Purchase +5,000 $0.53 $3K 72,521
2023-06-15 Huntsman Ronald Kirk Chief Executive Officer Purchase +21 $0.50 $11 57,521
2023-06-14 Huntsman Ronald Kirk Chief Executive Officer Purchase +10,000 $0.49 $5K 57,500
2022-12-23 Huntsman Ronald Kirk Chief Executive Officer Purchase +20,000 $0.50 $10K 47,500
2022-12-23 Huntsman Ronald Kirk Chief Executive Officer Grant or award · Stock Option (Right to Buy) +333,334 $0.48 $160K 333,334
2022-12-23 Huntsman Ronald Kirk Chief Executive Officer Grant or award · Stock Option (Right to Buy) +150,000 $0.48 $72K 483,334
2022-06-01 Huntsman Ronald Kirk Chief Executive Officer Purchase +4,000 $1.83 $7K 27,500
2022-05-31 Huntsman Ronald Kirk Chief Executive Officer Purchase +8,000 $2.03 $16K 23,500
2022-02-25 Huntsman Ronald Kirk Chief Executive Officer Grant or award · Stock Option (Right to Buy) +125,000 $3.27 $409K 125,000
2021-09-21 Huntsman Ronald Kirk Chief Executive Officer Purchase +5,000 $4.31 $22K 15,500
2021-08-17 Huntsman Ronald Kirk Chief Executive Officer Purchase +5,000 $3.00 $15K 10,500
2021-05-25 Huntsman Ronald Kirk Chief Executive Officer Purchase +4,000 $5.38 $22K 5,500
2020-12-23 Huntsman Ronald Kirk Chief Executive Officer Purchase +1,000 $7.27 $7K 1,500
2020-12-11 Huntsman Ronald Kirk Chief Executive Officer Purchase +500 $8.50 $4K 500

Page 1 of 1 · 20 trades